A 4-gene signature predicts prognosis of uterine serous carcinoma
Abstract Background Uterine serous carcinoma (USC) is an aggressive type of endometrial cancer that accounts for up to 40% of endometrial cancer deaths, creating an urgent need for prognostic biomarkers. Methods USC RNA-Seq data and corresponding patients’ clinical records were obtained from The Can...
Main Authors: | Hui Chen, Lingjun Li, Ping Qin, Hanzhen Xiong, Ruichao Chen, Minfen Zhang, Qingping Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-07834-4 |
Similar Items
-
Pathogenesis and Clinical Management of Uterine Serous Carcinoma
by: Li Zhang, et al.
Published: (2020-03-01) -
Clinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases
by: Wang Y, et al.
Published: (2018-10-01) -
Superior vena cava syndrome associated with uterine serous carcinoma
by: Anya Laibangyang, et al.
Published: (2020-08-01) -
Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma
by: Silvia Pelligra, et al.
Published: (2020-05-01) -
Brain metastasis from uterine serous carcinoma: A case report and review of literature
by: Tania Sierra, et al.
Published: (2015-01-01)